My monthly update and commentary on the top dividend stock picks from the Barron's Better Bets list, May 2025 edition. Read ...

Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.

NewYork-Presbyterian Health reduced its workforce by 2%, or about 1,000 employees. Nurses voiced concerns that the layoffs unnecessarily harmed care.

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...

U.S. President Donald Trump signed an executive order this week to lower the cost of prescription drugs in the United States by requiring drug companies to match the lower prices found in other countr ...